Fulton Breakefield Broenniman’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,679
Closed -$729K 170
2020
Q3
$729K Sell
2,679
-41
-2% -$11.2K 0.08% 84
2020
Q2
$790K Buy
2,720
+24
+0.9% +$6.97K 0.1% 81
2020
Q1
$642K Buy
2,696
+45
+2% +$10.7K 0.1% 83
2019
Q4
$580K Buy
2,651
+315
+13% +$68.9K 0.07% 105
2019
Q3
$396K Buy
+2,336
New +$396K 0.05% 120